David J. Rayhan

Dr. David Rayhan is board-certified in Dermatology and Micrographic Dermatologic (Mohs) Surgery by the American Board of Dermatology. Dr. Rayhan offers a complete spectrum of dermatology care at his practice including: medical dermatology, dermatologic surgery, cosmetic dermatology, advanced laser and injectable treatments. Dr. Rayhan also offers UVB and PUVA Phototherapy for treatment of vitiligo, psoriasis, eczema and other conditions without the need for systemic medications.

Dr. Rayhan earned his Bachelor of Science degree in Biological Sciences with honors from the University of California-Irvine. He then earned his M.D. from the University of California-Irvine School of Medicine. While at UC-Irvine Dr. Rayhan conducted research on the prevention of skin damage due to radiation treatments for cancer and also in laser treatment of vascular skin lesions. His work was published in the journal Dermatologic Surgery.

Following medical school, Dr. Rayhan completed his internship at the University of Nevada School of Medicine and the University Medical Center of Southern Nevada – the state's only burn center, center for limb and finger reattachment, center for organ transplantation, and the state's only Level one trauma center.

Dr. Rayhan completed his residency in dermatology at Harbor-UCLA Medical Center where he also served as Chief Resident. While serving as Chief Resident, Dr. Rayhan was awarded a grant from the American Society for Dermatologic Surgery to perform a preceptorship in cosmetic dermatology with Dr. Vic Narurkar at the Bay Area Laser Institute in San Francisco. During his residency, Dr. Rayhan also had training at the renowned cancer center at City of Hope National Medical Center and gained experience in pediatric dermatology working at Children's Hospital Los Angeles. In addition, Dr. Rayhan was awarded a prize for Top Presentation at the annual Cosmetic Surgery Forum. His findings were published in the journal SKINmed.

Dr. Rayhan further advanced his training through a fellowship at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. There he worked with Dr. Michael Kolodney MD PhD, the inventor of Kybella the world's only FDA approved drug for reduction of fat under the chin. During fellowship Dr. Rayhan also conducted the first study that sequenced and analyzed the genome of the most common form of skin cancer called basal cell carcinoma. His findings were published in the Journal of Investigative Dermatology.